Malignant<unk>  (MMMT) is a rare uterine sarcoma or carcinosarcoma.<unk> s are normally composed of both carcinomatous (epithelial) and sarcomatous (mesodermal) components.<unk>  may be classified according to pathology findings into 2 types: epitheloid subtype and sarcomatoid subtype.<unk>  may also be classified according to anatomical location into 7 types:  uterine corpus, cervix, ovaries, fallopian tubes, vagina, peritoneum, and extragenital sites. Common risk factors in the development of<unk>  are exposure to radiation, excessive estrogen exposure, obesity, and nulliparity.<unk>  is more commonly observed among postmenopausal women  between 50 and 60 years old. Early clinical features include postmenopausal vaginal bleeding, pelvic pain, and vaginal discharge.<unk> s are rare, and they only account for 3 to 4% of all uterine malignancies. The estimated prevalence of<unk>  is 3 cases per 100,000 women in the United States. The diagnosis of<unk>  is made with biopsy. Biopsy findings of<unk> , include: tumor with carcinomatous and sarcoma-like elements and angiolymphatic invasion. Surgery is the mainstay of therapy for<unk> . Total hysterectomy in conjunction with surgical staging is the most common approach to the treatment of<unk> . Prognosis is generally poor, and the 5-year survival rate of patients with<unk>  is approximately 33% to 39%.
Mixed mullerian tumor
Mixed Mullerian tumor
Ovarian germ cell tumor
Granulosa cell tumour
Gonadoblastoma
Prolactinoma
Germ cell tumor
Ovarian fibroma